Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function

International Journal of Cardiology

Volumn 121, Issue 1, 2007, Pages 57-61

  Bertrand, Michel E ^a   Remme, Willem J ^b   Fox, Kim M ^c   Ferrari, Roberto ^d   Simoons, Maarten L ^e  

^a Lille Heart Institute   (France)

^b Sticares Cardiovascular Research Foundation   (Netherlands)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d UNIVERSITY OF FERRARA   (Italy)

^e ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

ACE inhibition; Cardiovascular disease prevention; Coronary artery disease; Left ventricular dysfunction; Secondary prevention

Indexed keywords

ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; NITRIC ACID DERIVATIVE; PERINDOPRIL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DEMOGRAPHY; DRUG EFFECT; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HAZARD ASSESSMENT; HEART ARREST; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HOSPITAL ADMISSION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; RESUSCITATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SECONDARY PREVENTION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSTABLE ANGINA PECTORIS;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CORONARY ARTERIOSCLEROSIS; FEMALE; HEART ARREST; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); PERINDOPRIL; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 34548034184     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.11.100     Document Type: Article

References (14)

1. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Lancet 342 (1993) 821-828
2. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327 (1992) 669-677
3. Kober L., Torp-Pedersen C., Carlsen J.E., et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 333 (1995) 1670-1676
4. Ambrosioni E., Borghi C., and Magnani B. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators [see comments]. N Engl J Med 332 (1995) 80-85
5. Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1). Lancet 345 (1995) 686-687
6. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 345 (1995) 669-685
7. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. Lancet 343 (1994) 1115-1122
8. SOLVD investigators. Effect of enalaril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 325 (1991) 293-302
9. Flather M.D., Yusuf S., Kober L., et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group [see comments]. Lancet 355 (2000) 1575-1581
10. Kober L., Torp-Pedersen C., Carlsen J.E., et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group [see comments]. N Engl J coronary S Med 333 (1995) 1670-1676
11. Pitt B., O'Neill B., Feldman R., et al. The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function. Am J Cardiol 87 (2001) 1058-1063
12. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., and Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342 (2000) 145-153
13. Fox K.M. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362 (2003) 782-788
14. PEACE investigators. Angiotensin-converting-enzyme in stable coronary artery disease. N Engl J Med 351 (2004) 2058-2068